Sentinel Lymph Nodes in Cutaneous Melanoma

Surgical Pathology Clinics

Volumn 2, Issue 3, 2009, Pages 553-563

  Prieto, Victor G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Capsular nevus; Immunoperoxidase; Melanoma; Sentinel lymph node; Tumor burden

Indexed keywords

CANCER STAGING; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE;

EID: 70350494021     PISSN: 18759181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.path.2009.08.003     Document Type: Review

References (41)

1. Kaur C., Thomas R.J., Desai N., et al. The correlation of regression in primary melanoma with sentinel lymph node status. J Clin Pathol 61 3 (2008) 297-300
2. Prieto V.G. Use of frozen sections in the examination of sentinel lymph nodes in patients with melanoma. Semin Diagn Pathol 25 2 (2008) 112-115
3. Messina J.L., Glass L.F., Cruse C.W., et al. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 23 6 (1999) 686-690
4. Creager A.J., Shiver S.A., Shen P., et al. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer 94 11 (2002) 3016-3022
5. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 6 (1998) 2253-2260
6. Clary B.M., Brady M.S., Lewis J.J., et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233 2 (2001) 250-258
7. Cochran A.J. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 23 10 (1999) 1169-1172
8. Prieto V.G., and Clark S.H. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 6 4 (2002) 257-264
9. Gibbs J.F., Huang P.P., Zhang P.J., et al. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 6 7 (1999) 699-704
10. Yu L.L., Flotte T.J., Tanabe K.K., et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86 4 (1999) 617-627
11. Shidham V.B., Qi D.Y., Acker S., et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 25 8 (2001) 1039-1046
12. Abrahamsen H.N., Hamilton-Dutoit S.J., Larsen J., et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 100 8 (2004) 1683-1691
13. Shidham V.B., Qi D., Rao R.N., et al. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW Melanoma Cocktail' - a mixture of monoclonal antibodies to MART-1, melan-A, and tyrosinase. BMC Cancer 3 1 (2003) 15
14. Prieto V.G., and Shea C.R. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol 35 Suppl 2 (2008) 1-10
15. Trejo O., Reed J.A., and Prieto V.G. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation. J Cutan Pathol 29 7 (2002) 397-406
16. Carson K.F., Wen D.R., Li P.X., et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 20 7 (1996) 834-840
17. Lohmann C.M., Iversen K., Jungbluth A.A., et al. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am J Surg Pathol 26 10 (2002) 1351-1357
18. Biddle D.A., Evans H.L., Kemp B.L., et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol 27 5 (2003) 673-681
19. Prieto V.G., Diwan A.D., Lazar A.F.J., et al. Histologic quantification of tumor size in sentinel lymph node metastases correlates with prognosis in patients with cutaneous malignant melanoma. Mod Pathol 19 Suppl1 (2006) 87A
20. Batistatou A., Cook M.G., and Massi D. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the dermatopathology Working Group of the European Society of Pathology. Virchows Arch 454 5 (2009) 505-511
21. Cascinelli N., Belli F., Santinami M., et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7 6 (2000) 469-474
22. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 3 (1999) 976-983
23. Rousseau Jr. D.L., Ross M.I., Johnson M.M., et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 10 5 (2003) 569-574
24. Topping A., Dewar D., Rose V., et al. Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience. Br J Plast Surg 57 2 (2004) 97-104
25. Frankel T.L., Griffith K.A., Lowe L., et al. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?. Ann Surg Oncol 15 9 (2008) 2403-2411
26. Page A.J., Carlson G.W., Delman K.A., et al. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg 73 7 (2007) 674-678 [discussion: 678-79]
27. Debarbieux S., Duru G., Dalle S., et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 157 1 (2007) 58-67
28. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 1 (2005) 37-47
29. Gershenwald J.E., Andtbacka R.H., Prieto V.G., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 26 26 (2008) 4296-4303
30. Guggenheim M., Dummer R., Jung F.J., et al. The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma-a retrospective analysis of 392 cases. Br J Cancer 98 12 (2008) 1922-1928
31. Dewar D.J., Newell B., Green M.A., et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22 16 (2004) 3345-3349
32. Rossi C.R., De Salvo G.L., Bonandini E., et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol 15 4 (2008) 1202-1210
33. van Akkooi A.C., Bouwhuis M.G., de Wilt J.H., et al. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg 94 10 (2007) 1293-1299
34. Wright B.E., Scheri R.P., Ye X., et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg 143 9 (2008) 892-899 [discussion: 899-900]
35. Guggenheim M.M., Hug U., Jung F.J., et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg 247 4 (2008) 687-693
36. Satzger I., Völker B., Al Ghazal M., et al. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 50 6 (2007) 764-772
37. Romanini A., Manca G., Pellegrino D., et al. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome. Ann Oncol 16 11 (2005) 1832-1840
38. Gradilone A., Ribuffo D., Silvestri I., et al. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance. Ann Surg Oncol 11 11 (2004) 983-987
39. Mocellin S., Hoon D.S., Pilati P., et al. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 25 12 (2007) 1588-1595
40. Scoggins C.R., Ross M.I., Reintgen D.S., et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 24 18 (2006) 2849-2857
41. Hershko D.D., Robb B.W., Lowy A.M., et al. Sentinel lymph node biopsy in thin melanoma patients. J Surg Oncol 93 4 (2006) 279-285